BGLC
BioNexus Gene Lab·NASDAQ
--
--(--)
--
--(--)
BGLC fundamentals
BioNexus Gene Lab (BGLC) Revenue Breakdown: Q3 2025 Business & Regional Performance
BioNexus Gene Lab (BGLC) reported total revenue of 2.54M USD in Q3 2025, with its core business segment Trading of Industrial Chemicals contributing 99.81%. Regionally, Bangladesh remained the largest market, accounting for 3.07% of total revenue. Explore BioNexus Gene Lab's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
BioNexus Gene Lab (BGLC) reported total revenue of 2.54M USD in Q3 2025, with its core business segment Trading of Industrial Chemicals contributing 99.81%. Regionally, Bangladesh remained the largest market, accounting for 3.07% of total revenue. Explore BioNexus Gene Lab's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What guidance did BioNexus Gene Lab's management provide for the next earnings period?What is BioNexus Gene Lab's gross profit margin?What is the revenue and EPS growth rate for BioNexus Gene Lab year over year?What is BioNexus Gene Lab's latest dividend and current dividend yield?What is the market's earnings forecast for BioNexus Gene Lab next quarter?What were the key takeaways from BioNexus Gene Lab's earnings call?What factors drove the changes in BioNexus Gene Lab's revenue and profit?What does BioNexus Gene Lab do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
